Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1672-1692
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Figure 7 Impact of glycyrrhetinic acid on signal proteins in the phosphatidylinositol 3-kinase/protein kinase B signaling pathway.
A: Expression levels of insulin receptor and glycogen synthase kinase-3 proteins; B: Protein levels of phosphatidylinositol 3-kinase (PI3K)/p-PI3K and protein kinase B (AKT)/p-AKT. The sequence from left to right represents the control group, the model group, and the glycyrrhetinic acid group. aP < 0.05, bP < 0.01, cP < 0.001. GA: Glycyrrhetinic acid; CON: Control; MOD: Model; GSK3: Glycogen synthase kinase-3; INSR: Insulin receptor; AKT: Protein kinase B; PI3K: Phosphatidylinositol 3-kinase.
- Citation: Meng FD, Yuan L, Xu DJ, Che MY, Hou SZ, Lu DD, Liu WJ, Nan Y. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking. World J Diabetes 2023; 14(11): 1672-1692
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1672.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1672